Understanding how immune responses damage nerve cells in optic neuritis

Mechanisms of immune-mediated neuronal damage in a mouse model of optic neuritis

NIH-funded research Medical College of Wisconsin · NIH-11066231

This study is looking at how the immune system can harm nerve cells in the eyes during optic neuritis, which is often seen in multiple sclerosis, and it hopes to find new ways to protect vision by understanding the role of certain proteins in this process.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin NIH-funded
Lab location1 site (Milwaukee, United States)
Project IDNIH-11066231 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which immune-mediated damage occurs in nerve cells during optic neuritis, a common symptom of multiple sclerosis. Using a mouse model, the study focuses on how immune cells can destabilize microtubules in neurons, leading to inflammation and potential vision loss. The researchers aim to uncover the underlying processes that contribute to neuronal damage, which could help in developing new therapeutic strategies. By examining the role of tau protein and its hyperphosphorylation, the study seeks to provide insights that could be applicable to other neurodegenerative conditions as well.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who experience symptoms of optic neuritis.

Not a fit: Patients with optic neuritis not related to multiple sclerosis or those with other unrelated neurological conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for optic neuritis and potentially other neurodegenerative diseases by targeting the mechanisms of neuronal damage.

How similar studies have performed: Previous research has shown promising results in understanding immune-mediated neuronal damage in other contexts, suggesting that this approach may yield valuable insights.

Where this research is happening

Milwaukee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.